Dr. Rosenblum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3306 Kent St
Kensington, MD 20895Phone+1 301-949-3378Fax+1 301-480-3661
Summary
- I am Board Certified in Internal Medicine, Hematology, and Oncology, spent over 30 years serving patients in my community, providing leadership in the hospital, hospice, the cancer society, and the national organizations, ASH & ASCO. I left practice to work at the FDA and the NIH, again taking leadership roles in gene therapy, islet cell transplantation, and hematology research.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1970 - 1971
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1966 - 1968
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1966
Certifications & Licensure
MD State Medical License 1970 - 2023
DC State Medical License 1973 - 2006- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 1996
Publications & Presentations
PubMed
- 48 citationsThe rapidly changing US illicit drug market and the potential for an improved early warning system: evidence from Ohio drug crime labsDaniel Rosenblum, Jay Unick, Daniel Ciccarone
Drug and Alcohol Dependence. 2020-03-01 - 100 citationsNationwide increase in hospitalizations for heroin-related soft tissue infections: Associations with structural market conditions.Daniel Ciccarone, George J. Unick, Jenny K. Cohen, Sarah G. Mars, Daniel Rosenblum
Drug and Alcohol Dependence. 2016-06-01 - 46 citationsThe relationship between US heroin market dynamics and heroin-related overdose, 1992-2008.George J. Unick, Daniel Rosenblum, Sarah G. Mars, Daniel Ciccarone
Addiction. 2014-11-01
Press Mentions
Israeli Researchers Kill Cancer Cells with Genetic Editing TechnologyNovember 23rd, 2020
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
